Gut hormones: implications for the treatment of obesity.
about
Obesity pharmacotherapy: current perspectives and future directionsInterrelationships between ghrelin, insulin and glucose homeostasis: Physiological relevancePeripheral signals mediate the beneficial effects of gastric surgery in obesitySibutramine effects on central mechanisms regulating energy homeostasisNeuroimaging, gut peptides and obesity: novel studies of the neurobiology of appetite.Olfaction under metabolic influences.Suggestion of new possibilities in approaching individual variability in appetite through constitutional typology: a pilot studyGlucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits.Drug development strategies for the treatment of obesity: how to ensure efficacy, safety, and sustainable weight loss.Childhood obesity: a role for gut microbiota?The effect of family-based multidisciplinary cognitive behavioral treatment in children with obesity: study protocol for a randomized controlled trial.Current and future drug targets in weight managementGastrointestinal changes after bariatric surgery.Conjugated Linoleic Acid Supplementation under a High-Fat Diet Modulates Stomach Protein Expression and Intestinal Microbiota in Adult MiceThe effect of multidisciplinary lifestyle intervention on the pre- and postprandial plasma gut Peptide concentrations in children with obesity.Appetite regulation and weight control: the role of gut hormones.Prenatal exposure to persistent organochlorine pollutants is associated with high insulin levels in 5-year-old girls.Myostatin inhibition prevents diabetes and hyperphagia in a mouse model of lipodystrophy.Effects of exercise training on gut hormone levels after a single bout of exercise in middle-aged Japanese women.Maintenance on a high-fat diet impairs the anorexic response to glucagon-like-peptide-1 receptor activation.Correlations of circulating peptide YY and ghrelin with body weight, rate of weight gain, and time required to achieve the recommended daily intake in preterm infants.Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans.Association of vagus nerve severance and decreased risk of subsequent type 2 diabetes in peptic ulcer patients: An Asian population cohort study.Nutrition and L and K-enteroendocrine cells.Peptide hormones regulating appetite--focus on neuroimaging studies in humans.Exercise, appetite and appetite-regulating hormones: implications for food intake and weight control.Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: understanding weight loss and improvements in type 2 diabetes after bariatric surgery.The future of incretin-based therapy: novel avenues--novel targets.Current and emerging concepts on the role of peripheral signals in the control of food intake and development of obesity.Do we need anti-obesity drugs?Food ingredients as anti-obesity agents: a review.Loss of pons-to-hypothalamic white matter tracks in brainstem obesity.Hepatic leptin signalling and subdiaphragmatic vagal efferents are not required for leptin-induced increases of plasma IGF binding protein-2 (IGFBP-2) in ob/ob mice.Satiety Innovations: Food Products to Assist Consumers with Weight Loss, Evidence on the Role of Satiety in Healthy Eating: Overview and In Vitro Approximation.Influence of dietary protein and its amino acid composition on postoperative outcomes after gastric bypass surgery: a systematic review.Coffee consumption and the occurrence and intensity of metabolic syndrome: a cross-sectional study.Regulation of hindbrain Pyy expression by acute food deprivation, prolonged caloric restriction, and weight loss surgery in miceNeutralizing circulating ghrelin by expressing a growth hormone secretagogue receptor-based protein protects against high-fat diet-induced obesity in mice.Decreased intestinal nutrient response in diet-induced obese rats: role of gut peptides and nutrient receptors.Effect of different amounts of coffee on dietary intake and appetite of normal-weight and overweight/obese individuals.
P2860
Q26828559-E4B1861D-344C-4F2F-A3C4-2D8CB3603EDDQ26852874-D2FB243D-95C2-4D5B-B380-E52F049D5F80Q28088425-1A642190-294B-4A42-80EC-C84966BEC980Q30420884-6AAC0E73-EB1B-4AEB-9223-2FB98F0082D9Q33606106-9BC0942C-F7A2-40C5-B879-C5E602B0FA5FQ34290268-E77F363E-9ACD-42D2-92F4-74BC1B5AE69AQ34378436-609C1883-D006-4AFC-895C-A9BA7AC3EB29Q34379379-ADAFEEA8-AC5A-4577-B112-3D2C71C215D0Q34637579-4E7AAA87-9C9F-4C06-917A-509739FC303FQ35015022-4A170828-5E48-421E-96E4-FCBDAB4D1990Q35042329-54785E49-0217-46F9-80B8-15C114529CE1Q35089784-362FAFDE-2F83-4AB5-BF6E-993E38EC9F62Q35340286-6629CE7B-40E3-4733-ABEA-2F56D1819750Q35542798-EF3FDC67-0142-4CEC-85AD-51893AA686CCQ35684647-A7A46145-AC59-4861-87DC-AD8ACFDE5B02Q35825708-79B6FE3F-7FB2-4D6D-9565-9F3EA4690E38Q36172563-4D9EE20F-BB8B-49C9-899A-056E7F5B96EBQ36249775-F2E904FB-A54B-4A89-82C9-9FB8AC44732EQ36684108-60CB8D42-D78D-4C25-8EB4-DF5A8E90DEF5Q36882590-20C2889C-AE72-48B9-A347-C75802AE25E9Q37371107-B12C129C-5EC6-4980-A1D2-83190799795CQ37471710-C3393826-2E66-4EDC-B5F4-9B99D8FE75B2Q37606057-077715EC-65B8-41F5-B156-71E36744F67CQ37814881-185B7E98-1C64-4164-924B-784336C85F7CQ37835786-8EAA5831-2D55-4F98-AC57-99CDF7862B61Q37846435-3E94B75F-A319-4C27-9063-8F698D0FECF4Q37862878-ECA52461-FF3F-4189-8681-6EA47260824AQ37913528-E252C6F4-B611-4A5A-94AA-075BB3E59F43Q37992743-56E10D89-279C-45A6-BAD9-C921368F4223Q38071006-F8EB6903-A6FF-4FA7-8ED6-A7F5A8BA6BB9Q38114511-7FC52D47-2D00-4590-B6D8-11F9A51A24E2Q38204193-52705F47-3181-4D99-A4C2-1AECEDC1E449Q38329197-11E81804-3E8A-43C9-AF4B-E4D30B68F0FEQ38723698-EFE18475-9A04-43A9-B74D-547D14F9ACD4Q38793432-E3288425-94B7-4B0E-A769-090B6C2404FEQ39189416-CC4C5444-DD9E-47B1-98AE-6246BC4A7DE5Q41831322-608C3A85-0738-4DE2-9396-1D002811C843Q45875896-6ACF2A2F-6A3C-46B1-951A-31C4FA096E4CQ46811140-0E07492E-34F5-4826-A2BB-844665AA58E3Q46990007-3F540699-DBDE-4700-A810-211B052053DF
P2860
Gut hormones: implications for the treatment of obesity.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Gut hormones: implications for the treatment of obesity.
@ast
Gut hormones: implications for the treatment of obesity.
@en
type
label
Gut hormones: implications for the treatment of obesity.
@ast
Gut hormones: implications for the treatment of obesity.
@en
prefLabel
Gut hormones: implications for the treatment of obesity.
@ast
Gut hormones: implications for the treatment of obesity.
@en
P1476
Gut hormones: implications for the treatment of obesity.
@en
P2093
Marianne T Neary
P356
10.1016/J.PHARMTHERA.2009.06.005
P577
2009-06-26T00:00:00Z